| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/29/2004 | US20040019008 Compositions and processes using siRNA, amphipathic compounds and polycations |
| 01/29/2004 | US20040019007 Intravascular delivery of non-viral nucleic acid |
| 01/29/2004 | US20040019004 Anticancer agents; antitumor agents |
| 01/29/2004 | US20040019003 Nek2 inhibitors |
| 01/29/2004 | US20040019002 Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site |
| 01/29/2004 | US20040019001 Modulation gene expression |
| 01/29/2004 | US20040019000 Cellular uptake of immobilized oligomers |
| 01/29/2004 | US20040018999 Methods and compositions for RNA interference |
| 01/29/2004 | US20040018982 Nematicidal proteins |
| 01/29/2004 | US20040018980 Novel FIZZ proteins |
| 01/29/2004 | US20040018979 Anticholesterol agents |
| 01/29/2004 | US20040018973 Diagnosis cell proliferation; binding antibody to nucleic acids |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018967 Ligand/lytic peptide compositions and methods of use |
| 01/29/2004 | US20040018962 Drug delivery vehicles |
| 01/29/2004 | US20040018627 High-efficiency AAV helper functions |
| 01/29/2004 | US20040018626 Replacement of immunoglobulin in endogenous cells; forming embryos stem cell |
| 01/29/2004 | US20040018625 Inducible methods for repressing gene function |
| 01/29/2004 | US20040018624 Compositions and methods for making mutations in cell lines and animals |
| 01/29/2004 | US20040018622 Therapy for skin disorders; genetic defects |
| 01/29/2004 | US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy |
| 01/29/2004 | US20040018617 Culture product of animal cells; mammal embryo stem cells |
| 01/29/2004 | US20040018613 Method for producing a microarray |
| 01/29/2004 | US20040018610 Slip cover for heated platen assembly |
| 01/29/2004 | US20040018605 Anticancer agents; autoimmune diseases; central nervous system disorders; polymerase chain reactions |
| 01/29/2004 | US20040018602 Adjust tocopherol in plant cells; nucleic acid construct |
| 01/29/2004 | US20040018600 Microbial conversion of glucose to para-hydroxystyrene |
| 01/29/2004 | US20040018598 Chemical intermediate for discodermolide, epothilone |
| 01/29/2004 | US20040018597 Methods for making polyketides |
| 01/29/2004 | US20040018596 Process for producing polypeptide having disulfide bond |
| 01/29/2004 | US20040018595 Production of recombinant bmp-2 |
| 01/29/2004 | US20040018593 Anti-RELP fusion antibodies, compositions, methods and uses |
| 01/29/2004 | US20040018592 Purity; genetic engineering |
| 01/29/2004 | US20040018591 Methods and compositions for protein expression and purification |
| 01/29/2004 | US20040018590 Glycosylation; genetic engineering; Dna libraries |
| 01/29/2004 | US20040018588 Protein glycosylation modification in methylotrophic yeast |
| 01/29/2004 | US20040018586 Method for refolding proteins containing free cysteine residues |
| 01/29/2004 | US20040018572 Mutant Plk protein and gene encoding the same |
| 01/29/2004 | US20040018569 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018553 Reagents and methods useful for detecting diseases of the prostate |
| 01/29/2004 | US20040018552 Immobilization; controlling length; coupling to label; biosynthesis |
| 01/29/2004 | US20040018551 Purification of Dna, Rna; hydration, mixing with chaotropic agent and reducing agents; heating controlling temperature; polymerase chain reaction, amplification |
| 01/29/2004 | US20040018550 Antibodies immunologically specific for a DNA repair endonuclease and methods of use thereof |
| 01/29/2004 | US20040018549 Antiinflammatory agents; induction immunology response; binding to antibody |
| 01/29/2004 | US20040018547 Ion channel receptor and uses thereof |
| 01/29/2004 | US20040018543 Incubation; controlling temperature and pH |
| 01/29/2004 | US20040018542 Phosphodiesterase enzymes |
| 01/29/2004 | US20040018541 Isolated nucleic acids; chimera gene; adjust gene expression |
| 01/29/2004 | US20040018540 Evaluation method of interferon beta treatment against multiple sclerosis |
| 01/29/2004 | US20040018539 Oligonucleotides for use in determining the presence of human papilloma virus in a test sample |
| 01/29/2004 | US20040018538 Mitochondrial dosimeter |
| 01/29/2004 | US20040018537 Genes for detecting bacteria and a method for detecting bacteria by using the genes |
| 01/29/2004 | US20040018536 Molecule for assigning genotype to phenotype and components thereof as well as method for constructing assigning molecule and method for utilizing assigning molecule |
| 01/29/2004 | US20040018534 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein |
| 01/29/2004 | US20040018533 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 01/29/2004 | US20040018531 Methods of identifying and isolating stem cells and cancer stem cells |
| 01/29/2004 | US20040018529 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage |
| 01/29/2004 | US20040018525 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasma |
| 01/29/2004 | US20040018524 Method of screening for genes that influence pathological conditions or survival of animals infected with pathogen |
| 01/29/2004 | US20040018518 Analyzing Dna sequences; genetic engineering; measurement glyphosate tolerance in plant |
| 01/29/2004 | US20040018516 Ixodes scapularis tissue factor pathway inhibitor |
| 01/29/2004 | US20040018515 Quantitative analysis; using nucleic acids; binding to aptamer |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018506 Methods and systems for ordering assays which detect gene expression; collections of stock assays are assembled using pre- and post- manufacturing quality control procedures and made available to consumers via the Internet |
| 01/29/2004 | US20040018504 Method for extracting quantitative information relating to interactions between cellular components |
| 01/29/2004 | US20040018498 Peptide and nucleic acid arrays; used in gene expression analysis, drug screening, nucleic acid sequencing, mutation analysis, and the like |
| 01/29/2004 | US20040018495 Microparticle based signal amplification for the detection of analytes |
| 01/29/2004 | US20040018490 Antibiotic-based gene regulation system |
| 01/29/2004 | US20040018488 Detection of human herpes virus 6 (HHV6) |
| 01/29/2004 | US20040018208 A part of the coding sequence of the middle glycoprotein of the hepatitis B virus, which has a dna sequence coding for at least one tumor epitope of a tumor antigen inserted |
| 01/29/2004 | US20040018205 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 01/29/2004 | US20040018198 Antibodies against carbonic anydrase IX (CA IX) tumor antigen |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018191 Neutralizing human anti-IGFR antibody |
| 01/29/2004 | US20040018181 MUC1 interference RNA compositions and methods derived therefrom |
| 01/29/2004 | US20040018178 Ablation of bone marrow and grafting genetic engineered isogeneic, allogeneic or xenogeneic cells, for prophylaxis of tumors or cancer |
| 01/29/2004 | US20040018176 Compositions and methods for siRNA inhibition of angiogenesis |
| 01/29/2004 | US20040018173 Composition and method for the treatment and prevention of metastatic disorders |
| 01/29/2004 | DE19964268B4 Verfahren zum Screenen einer Verbindung, welche die Wechselwirkung zwischen IGF-1R und einem der Polypeptide IIP-1 bis IIP-10 hemmt A method for screening a compound which inhibits the interaction between IGF-1R and IIP-one of the polypeptides 1 to IIP-10 |
| 01/29/2004 | DE19952982B4 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 01/29/2004 | DE10231589A1 Klonierung und Charakterisierung einer Lipoxygenase aus Phaeodactylum tricornutum Cloning and characterization of a lipoxygenase from Phaeodactylum tricornutum |
| 01/29/2004 | DE10231588A1 Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen The transgenic expression constructs and methods for increasing the vitamin E content in plant organisms |
| 01/29/2004 | DE10231587A1 Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen The transgenic expression constructs and methods for increasing the vitamin E content in plant organisms |
| 01/29/2004 | DE10229872A1 Immunstimulation durch chemisch modifizierte RNA Immune stimulation by chemically modified RNA |
| 01/29/2004 | DE10229379A1 EG-VEGF Rezeptor Antagonisten EG-VEGF receptor antagonists |
| 01/29/2004 | CA2851035A1 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 01/29/2004 | CA2493679A1 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | CA2493564A1 Novel sirna libraries and their production and use |
| 01/29/2004 | CA2493499A1 Compositions and methods for sirna inhibition of angiogenesis |
| 01/29/2004 | CA2493432A1 Fusion proteins comprising a modified albumin signal sequence |
| 01/29/2004 | CA2493406A1 Gm-negative ehv-mutants without heterologous elements |
| 01/29/2004 | CA2493263A1 Novel gene associated with rheumatoid arthritis |
| 01/29/2004 | CA2493254A1 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 01/29/2004 | CA2493251A1 Single promoter system for making sirna expression cassettes and expression libraries using a polymerase primer hairpin linker |
| 01/29/2004 | CA2493232A1 Antisense compounds, methods and compositions for treating mmp-12 related inflammatory disorders |
| 01/29/2004 | CA2493007A1 Protein complexes of the tip60 transcriptional activator protein |
| 01/29/2004 | CA2492919A1 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 01/29/2004 | CA2492784A1 Method for obtaining pathogen resistance in plants by double-stranded rna gene silencing of nadph oxidase |